about
Antimicrobial Resistance Patterns in Women with Positive Urine Culture: Does Menopausal Status Make a Significant Difference?Urinary retention in female OAB after intravesical Botox injection: who is really at risk?Both the middle and distal sections of the urethra may be regarded as optimal targets for 'outside-in' transobturator tape placementAnatomical variation of bony pelvis from the viewpoint of transobturator sling placement for stress urinary incontinence.Effectiveness of botulinum toxin injection in the treatment of de novo OAB symptoms following midurethral sling surgery.Ultrasound imaging in urogynecology - state of the art 2016.Impact of intravesical onabotulinumtoxinA on sexual function in women with OAB.Can botox improve night-time overactive bladder symptoms in women?Serum concentrations of markers of type I collagen metabolism in women taking monophasic oral contraceptives.Most of the patients with suburethral sling failure have tapes located outside the high-pressure zone of the urethra.Leiomyomatosis peritonealis disseminata with formation of endometrial cysts within tumors arising after supracervical laparoscopic hysterectomy.Collagen deposition around polypropylene tapes implanted in the rectus fascia of female rats.Relationship between estrogen receptor-alpha polymorphism and serum levels of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, C-reactive protein and homocysteine in postmenopausal women.Use of free uroflowmetry vs pressure-flow studies in the diagnosis of overactive bladder syndrome in females.Transobturator midurethral sling: What should patients expect after surgery?[Stress urinary incontinence among women who underwent surgical treatment due to abdominal hernias].Re: Midurethral Tissue Fixation System (TFS).Pelvic floor disorders: role of new ultrasonographic techniques.3-D high-frequency endovaginal ultrasound of female urethral complex and assessment of inter-observer reliability.Body mass index does not influence the outcome of anti-incontinence surgery among women whereas menopausal status and ageing do: a randomised trial.Opportunistic salpingectomy for prevention of sporadic ovarian cancer - a jump from basic science to clinical practice?Height at menarche is influenced by estrogen receptor alpha gene polymorphisms.Estrogen receptor alpha and beta expression in uterine leiomyomas from premenopausal women.Reply from authors to Letter to the Editor on "RE: Konrad Futyma, Łukasz Nowakowski, Michał Bogusiewicz, Alicja Ziętek, Andrzej P. Wieczorek and Tomasz Rechberger. Use of Uroflow Parameters in Diagnosing an Overactive Bladder-Back to the Drawing BUse of uroflow parameters in diagnosing an overactive bladder-Back to the drawing boardCan Intradetrusor OnabotulinumtoxinA Injections Alter Heart Function in Patients with Cardiac Arrhythmia?Interstitial collagenase (MMP-1) activity in human ovarian tissueGlobal DNA methylation in relation to hMLH1 and hMSH2 protein immunoreactivity in sporadic human endometrial carcinomasBAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancersEvaluation of matrix metalloproteinases-1 and -3 concentrations in the tunica albuginea, the apical wall of atretic follicles and the corpus luteum of normal human ovariesLocal collagen turnover in human foetal membranes during full term vaginal delivery[Activity of tissue inhibitors of metal proteinases (TMI) in th fetal membrane during term vaginal delivery]Activity of matrix metalloproteinases-2 and -9 in advanced laryngeal cancerPrevalence of estrogen receptor alpha PvuII and XbaI polymorphism in population of Polish postmenopausal womenLack of correlation between leptin receptor expression and PI3-K/Akt signaling pathway proteins immunostaining in endometrioid-type endometrial carcinomas[Polymorhism of CYP17 gene and age of menarche][Activity of matrix metalloproteinases -2 and -9 (MMP-2 and MMP-9) and content of their tissue inhibitors in endometrial cancer--a preliminary study][Expression of tumor necrosis factor-alpha (TNF-alpha) on peritoneal fluid mononuclear cells in women with endometriosis]Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium[Matrix metalloproteinases and their inhibitors in ovarian cancer progression--diagnostic and therapeutic implications]
P50
Q33608087-A757844E-0684-4D11-8631-2ADF9EF668DFQ33705306-6FA585EE-6B67-48AE-AA57-FB33E9681DEDQ34538480-09A5A096-E0C8-487E-B15C-B95A03111A19Q35093710-52CE0DFF-9C65-4AF4-8720-968C05DD7F83Q36615109-EF5CE791-2129-4636-9D40-C5753A5527FDQ37473128-B64E39D3-64B1-42B0-8952-170EA42E26D8Q40554763-21C3DE4E-5114-4C10-8288-0D95FCA08E20Q40887604-4B178C9D-7CB8-47A3-B067-AE93D23C0B28Q43987071-4ECEC9B2-979A-453B-9856-1360B6A13F63Q44455175-F221C126-4B3C-4578-8477-B977C9C36BF8Q45126724-FA4E362D-BB49-4998-BAD1-C051FC6BFA20Q46606587-A863856C-6583-4454-80A5-C05787D37567Q46984672-E4476839-8BC5-44FD-AE15-A21327C8F16BQ47945665-5CBFD35F-FC68-47E8-8E04-6CDD9582004BQ48156563-274946FE-A3EC-4032-82F0-3B3B2B3A3FB7Q50185591-16C88693-DD8F-4BBC-89C7-DD7D7FFD852DQ51218821-98FAAC2A-9448-4061-979C-D4516EDDEC69Q51450700-6E620800-83BA-44C5-8AF0-F8AEC10F9CE7Q51536163-215B0BB8-A1B8-4A2E-8E6B-40E50D464F37Q51581676-0A2C244A-7CC5-4FF5-8541-952A4767326AQ53061246-8436760C-E354-496E-B14C-6F18ACC3A459Q54446963-74D5B553-21B8-4E5E-A942-DA7AC60C3C31Q54698268-AD839156-F81C-4620-AE3F-53665CD8C56FQ57135511-68632FD9-638D-4ED5-8471-B4230CB337D1Q57137642-062C1637-8276-496A-A869-CC485BED09E5Q58757054-EAB93A09-002F-4286-8B51-252874D30CC2Q73111582-A45EA4D8-176A-4510-8847-9A1C853B7FF9Q73235721-49D649F5-3801-4D12-B5F4-3567B6B9FAE1Q73492708-12023DD1-0EF1-4542-9148-B0E795BCC4E3Q73797010-2BA1EABB-8524-4D71-9AE2-B0C2DB4BE46FQ74523374-72105DBE-BB14-4965-80C7-AD6966734B04Q77405376-DE11AA3C-183A-4557-BCEF-D5A094C4CF4FQ78947422-A4C0CA02-6511-442E-810D-0399D82EE14FQ80422874-15D1D1A5-350D-4E1F-A0F3-67F669D31DEDQ81017748-C433359C-7B86-4909-B970-3F942BCB9642Q81083151-CD05CFEA-D72E-4E7F-97E3-05A0741CB3E1Q81292445-A99A9D71-0D54-494C-BCFD-881E38E22E7AQ81353777-07DF5194-578C-4AE1-8FFC-2ED38428E0FBQ81456048-1D76ABBE-9AE6-41C9-B351-BB4FEB20C0F0Q83561685-62024219-6657-49CA-9BDD-4DDF7337EC5A
P50
description
researcher
@en
wetenschapper
@nl
name
Bogusiewicz M
@nl
Michał Bogusiewicz
@en
type
label
Bogusiewicz M
@nl
Michał Bogusiewicz
@en
altLabel
Bogusiewicz M
@en
prefLabel
Bogusiewicz M
@nl
Michał Bogusiewicz
@en
P106
P31
P496
0000-0003-4959-1115